Extract from the Register of European Patents

EP About this file: EP0091511

EP0091511 - 1-(3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl)-4-(substituted)-piperazines and -piperidines, a process for the preparation thereof, pharmaceutical compositions containing the same and their use as medicaments [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.03.1989
Database last updated on 28.03.2026
Most recent event   Tooltip12.11.1999Lapse of the patent in a contracting statepublished on 29.12.1999 [1999/52]
Applicant(s)For all designated states
HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED
Route 202-206 North Somerville
New Jersey 08876 / US
[N/P]
Former [1983/42]For all designated states
HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED
Route 202-206 North
Somerville New Jersey 08876 / US
Inventor(s)01 / Davis, Larry
P.O. Box 129
Sergeantsville New Jersey 08557 / US
02 / Klein, Joseph Thomas
P.O. Box 6576
Bridgewater New Jersey 08807 / US
[1983/42]
Representative(s)Meyer-Dulheuer, Karl-Hermann, et al
Dr. Meyer- Dulheuer & Partners LLP
Franklinstrasse 61-63
60486 Frankfurt am Main / DE
[N/P]
Former [1983/42]Meyer-Dulheuer, Karl-Hermann, Dr., et al
Hoechst AG, Werk Kalle-Albert, Zentrale Patentabteilung KA
D-65174 Wiesbaden / DE
Application number, filing date82109801.923.10.1982
[1983/42]
Priority number, dateUS1982036624409.04.1982         Original published format: US 366244
US1982036624809.04.1982         Original published format: US 366248
[1983/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0091511
Date:19.10.1983
Language:EN
[1983/42]
Type: A3 Search report 
No.:EP0091511
Date:12.12.1984
Language:EN
[1984/50]
Type: B1 Patent specification 
No.:EP0091511
Date:11.05.1988
Language:EN
[1988/19]
Search report(s)(Supplementary) European search report - dispatched on:EP10.10.1984
ClassificationIPC:C07D261/20, C07D413/14, A61K31/445, A61K31/495
[1983/42]
CPC:
C07D413/12 (EP); C07D413/06 (KR); C07D261/20 (EP);
C07D413/14 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1983/42]
TitleGerman:1-(3-(6-Fluor-1,2-benzisoxazol-3-yl)propyl)-4-(substituierte)-piperazine und -piperidine, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung als Arzneimittel[1983/42]
English:1-(3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl)-4-(substituted)-piperazines and -piperidines, a process for the preparation thereof, pharmaceutical compositions containing the same and their use as medicaments[1983/42]
French:Pipérazines et -pipéridines-1-(3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl)-4-(substituées), procédé de leur préparation, compositions pharmaceutiques les contenant et leur application comme médicaments[1983/42]
Examination procedure26.02.1985Examination requested  [1985/19]
16.10.1986Despatch of a communication from the examining division (Time limit: M02)
13.12.1986Reply to a communication from the examining division
07.07.1987Despatch of communication of intention to grant (Approval: )
30.10.1987Communication of intention to grant the patent
28.01.1988Fee for grant paid
28.01.1988Fee for publishing/printing paid
Opposition(s)14.02.1989No opposition filed within time limit [1989/20]
Fees paidRenewal fee
12.09.1984Renewal fee patent year 03
11.09.1985Renewal fee patent year 04
12.09.1986Renewal fee patent year 05
14.09.1987Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipLU31.10.1988
[1999/52]
Documents cited:Search[A] JP51-136666  
 [A]   Chemical Abstracts, vol. 87, no. 5, 1 August 1977,Columbus, Ohio, USA; page 519, column 2, abstract no. 39459c & JP-A-51-136 666 [A]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.